Medicover AB
OTC:MCVEF

Watchlist Manager
Medicover AB Logo
Medicover AB
OTC:MCVEF
Watchlist
Price: 27.25 USD
Market Cap: $4.1B

EV/OCF

10.9
Current
21%
Cheaper
vs 3-y average of 13.8

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
10.9
=
Enterprise Value
$39.9B
/
Operating Cash Flow
€343.7m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
10.9
=
Enterprise Value
$39.9B
/
Operating Cash Flow
€343.7m

Valuation Scenarios

Medicover AB is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (13.8), the stock would be worth $34.62 (27% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+46%
Average Upside
36%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 10.9 $27.25
0%
3-Year Average 13.8 $34.62
+27%
5-Year Average 14.3 $35.9
+32%
Industry Average 15.2 $38.06
+40%
Country Average 15.9 $39.81
+46%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
SE
Medicover AB
OTC:MCVEF
30.3B USD 10.9 35.5
US
CVS Health Corp
NYSE:CVS
98.3B USD 13.9 55.2
US
Cigna Group
XMUN:CGN
69.3B EUR 10.6 13.4
US
Cigna Corp
NYSE:CI
72.9B USD 0 12.2
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.9B EUR 12.7 18.9
DE
Fresenius Medical Care AG
XMUN:FME
23.2B EUR 11 23.5
US
Quest Diagnostics Inc
NYSE:DGX
22.6B USD 14.2 22.4
US
Laboratory Corporation of America Holdings
NYSE:LH
22.5B USD 16.3 25.4
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR 6.5 11.2
US
Guardant Health Inc
NASDAQ:GH
11.8B USD -66.1 -28.1
US
DaVita Inc
NYSE:DVA
10.3B USD 10.4 13.9

Market Distribution

Lower than 96% of companies in Sweden
Percentile
4th
Based on 1 211 companies
4th percentile
1.5
Low
0.3 — 10.7
Typical Range
10.7 — 23.7
High
23.7 —
Distribution Statistics
Sweden
Min 0.3
30th Percentile 10.7
Median 15.9
70th Percentile 23.7
Max 9 494.9

Medicover AB
Glance View

Market Cap
4.1B USD
Industry
Health Care

Medicover AB, founded in 1995, is a prominent healthcare and diagnostic service provider, chiefly operating across Europe and India. The company, based out of Sweden, has carved a niche by offering a broad range of healthcare services, focusing on accessible and premium quality care. Medicover’s structure is multifaceted—comprising two main divisions: Healthcare Services and Diagnostic Services. Their healthcare division administers preventative and primary care services through outpatient clinics, as well as specialist hospital care, emphasizing a holistic approach to patient care. Meanwhile, the Diagnostic Services division performs a vital role, supplying an extensive array of laboratory and imaging services. This dual-pronged business model ensures a steady stream of revenue, bolstering Medicover’s position in the competitive healthcare landscape. The way Medicover makes money is intricately tied to its wide-reaching network and comprehensive service offerings. Revenues are primarily derived from the fees for healthcare and diagnostic services provided directly to patients and through contracts with insurance companies and corporate clients, who seek Medicover’s expertise in employee health management. In navigating the healthcare sector, Medicover leverages its robust technological infrastructure to optimize service delivery and operational efficiency, ensuring patient satisfaction while maintaining cost-effectiveness. By continuously expanding its geographical footprint and diversifying its service portfolio, Medicover is adept at adapting to evolving market demands, thus securing its long-term financial sustainability and reinforcing its commitment to delivering value-driven healthcare solutions.

MCVEF Intrinsic Value
43.05 USD
Undervaluation 37%
Intrinsic Value
Price $27.25
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett